
Tirzepatide ODT is a compounded oral disintegrating tablet that dissolves rapidly on the tongue without water. It activates dual GIP and GLP-1 receptors to support blood sugar regulation, appetite control, and weight management — no injection required.
Important: Tirzepatide ODT is available exclusively through a 503A compounding pharmacy pursuant to a patient-specific prescription. Compounded medications are not FDA-approved and have not been reviewed for safety or efficacy. Tirzepatide ODT has not undergone clinical trials.
Tirzepatide ODT delivers the active compound through an oral disintegrating tablet that begins dissolving immediately on contact with saliva — typically within seconds. This formulation is particularly well-suited for patients who have difficulty swallowing traditional tablets or prefer a needle-free alternative. Each tablet is compounded using specialized excipients to ensure uniform distribution of the active ingredient, rapid disintegration, and maintained potency throughout its beyond-use date.
Feel
Persistent hunger, uncontrolled cravings, or difficulty managing weight despite dietary changes
Want to support
Metabolic health, healthy weight loss, and long-term blood sugar regulation without injections
Experience
Blood sugar fluctuations, insulin resistance, or fatigue related to poor glucose control
Care about
Needle-free delivery, convenience, and a discreet format that fits easily into daily routines




Place the Tirzepatide ODT tablet directly on your tongue and allow it to dissolve completely — do not chew, crush, or swallow the tablet whole. The tablet typically dissolves within seconds upon contact with saliva. Take as directed by your prescribing provider. Your dose may be gradually increased over time to minimize gastrointestinal side effects and optimize response.
Tirzepatide ODT is a prescription-only compounded medication dispensed through a 503A pharmacy following physician evaluation. It has not been FDA-approved or reviewed for safety or efficacy. It is contraindicated in patients with a history of medullary thyroid carcinoma, MEN2, known hypersensitivity to tirzepatide, severe gastrointestinal disease, or in pregnant women. Cross-reactivity with other GLP-1 receptor agonists has been reported. California shipping is not available for this product.
Store Tirzepatide ODT tablets in a cool, dry place away from direct light and moisture. Keep at controlled room temperature unless otherwise directed by your compounding pharmacy. Do not store in humid environments such as bathrooms. Keep out of reach of children. Use within the beyond-use date specified on your prescription label.

© 2026, TestosteroneShots.com PC
text (323)-283-9219
638 1/2 N Robertson Blvd, West Hollywood, CA 90069
The information and products provided on this website are for educational and wellness purposes only and are not intended to diagnose, treat, cure, or prevent any disease. All treatments require evaluation and approval by a licensed healthcare provider through a telemedicine consultation. Individual results may vary, and products carry potential risks and side effects. Certain products may not be evaluated by the U.S. Food and Drug Administration (FDA) unless explicitly stated. Services are provided by licensed physicians and nurse practitioners in states where they are authorized to practice, including California, Florida, Nevada, and other participating states. This service is not intended for medical emergencies. If you are experiencing an emergency, call 911 or seek immediate medical care. We take reasonable measures to protect personal health information in accordance with applicable privacy laws, including HIPAA. By using this website or its services, you agree to our Terms of Service, Privacy Policy, and Telehealth Consent. You must be 18 years of age or older to use this service.